Phase I SCO-240 single dose study
Phase 1
- Conditions
- Cholelithiasis
- Registration Number
- JPRN-jRCT2051210027
- Lead Sponsor
- Araki Takahiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 76
Inclusion Criteria
Gender: Male
- Race:
Healthy Japanese adults: The subject's parents and grand parents are Japanese
Healthy Caucasian adults: The subject's parents and grandparents are Caucasian
- Age: Subjects are between 20 and 45 years, inclusive, at the time of informed consent
- Weight at screening:
Healthy Japanese adults: >=50 kg, body mass index (BMI) >=18.5 kg/m2 and =<25.0 kg/m2
Healthy Caucasian adults >=50 kg, BMI >=18.5 kg/m2 and =<30.0 kg/m2
Exclusion Criteria
- Subjects who have a present illness such as cardiovascular disease, central nervous system disease, gastrointestinal disease, hematopoietic disease, renal failure, metabolic or endocrine disorder, serious allergy, asthma, hypoxemia, hypertension, convulsion or allergic rash.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method